Manuel S. Rodríguez

8.7k total citations · 3 hit papers
104 papers, 7.1k citations indexed

About

Manuel S. Rodríguez is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Manuel S. Rodríguez has authored 104 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 40 papers in Oncology and 20 papers in Immunology. Recurrent topics in Manuel S. Rodríguez's work include Ubiquitin and proteasome pathways (76 papers), Cancer-related Molecular Pathways (20 papers) and interferon and immune responses (15 papers). Manuel S. Rodríguez is often cited by papers focused on Ubiquitin and proteasome pathways (76 papers), Cancer-related Molecular Pathways (20 papers) and interferon and immune responses (15 papers). Manuel S. Rodríguez collaborates with scholars based in Spain, France and United Kingdom. Manuel S. Rodríguez's co-authors include Ronald T. Hay, Joana Desterro, Catherine Dargemont, Sonia Laı́n, David P. Lane, Fernando Arenzana‐Seisdedos, Jill L. Thompson, Fernando Lopitz‐Otsoa, Dominique Thomas and Valérie Lang and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Manuel S. Rodríguez

102 papers receiving 7.1k citations

Hit Papers

SUMO-1 Modification of IκBα Inhibits NF-κB Activation 1998 2026 2007 2016 1998 2001 1999 250 500 750

Peers

Manuel S. Rodríguez
Ingrid E. Wertz United States
Arthur L. Haas United States
Jianping Jin United States
Andrew Oberst United States
Chunying Du United States
Eugene Varfolomeev United States
Tetsu Kamitani United States
Ingrid E. Wertz United States
Manuel S. Rodríguez
Citations per year, relative to Manuel S. Rodríguez Manuel S. Rodríguez (= 1×) peers Ingrid E. Wertz

Countries citing papers authored by Manuel S. Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Manuel S. Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel S. Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel S. Rodríguez more than expected).

Fields of papers citing papers by Manuel S. Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel S. Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel S. Rodríguez. The network helps show where Manuel S. Rodríguez may publish in the future.

Co-authorship network of co-authors of Manuel S. Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel S. Rodríguez. A scholar is included among the top collaborators of Manuel S. Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel S. Rodríguez. Manuel S. Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Haifeng, Rocío Seoane, Anxo Vidal, et al.. (2025). SUMOylation of the lysine-less tumor suppressor p14ARF counters ubiquitylation-dependent degradation. Cell Death and Disease. 16(1). 519–519.
2.
Xolalpa, Wendy, Raimundo Freire, Julie Guillermet‐Guibert, et al.. (2025). Role of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma. Cell Death Discovery. 11(1). 108–108. 1 indexed citations
3.
Seoane, Rocío, Antonia María Romero, Manuel S. Rodríguez, et al.. (2024). SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells. Cellular & Molecular Biology Letters. 29(1). 15–15. 3 indexed citations
4.
Carvalho, Ana Sofía, et al.. (2022). Isolation and Mass Spectrometry Identification of K48 and K63 Ubiquitin Proteome Using Chain-Specific Nanobodies. Methods in molecular biology. 2602. 125–136. 3 indexed citations
5.
Martínez‐Muñoz, Laura, et al.. (2021). Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL. Cells. 10(11). 2803–2803. 6 indexed citations
6.
Heidelberger, Jan B., Chantal Maghames, Aymeric Bailly, et al.. (2021). Proteome-wide identification of NEDD8 modification sites reveals distinct proteomes for canonical and atypical NEDDylation. Cell Reports. 34(3). 108635–108635. 40 indexed citations
7.
Barrio, Rosa, James D. Sutherland, & Manuel S. Rodríguez. (2020). Proteostasis and disease : from basic mechanisms to clinics. SPIRE - Sciences Po Institutional REpository. 4 indexed citations
8.
Lopitz‐Otsoa, Fernando, Teresa C. Delgado, Sofía Lachiondo‐Ortega, et al.. (2019). SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer. Journal of Visualized Experiments. 5 indexed citations
9.
Cruz-Herrera, Carlos F. de la, Manuel Collado, Anxo Vidal, et al.. (2017). Phosphorylable tyrosine residue 162 in the double-stranded RNA-dependent kinase PKR modulates its interaction with SUMO. Scientific Reports. 7(1). 14055–14055. 6 indexed citations
10.
Carvalho, Ana Sofía, Manuel S. Rodríguez, & Rune Matthiesen. (2016). Review and Literature Mining on Proteostasis Factors and Cancer. Methods in molecular biology. 1449. 71–84. 16 indexed citations
11.
Mata-Cantero, Lydia, Marı́a G. Gómez-Lorenzo, Wendy Xolalpa, et al.. (2015). Development of two novel high-throughput assays to quantify ubiquitylated proteins in cell lysates: application to screening of new anti-malarials. Malaria Journal. 14(1). 200–200. 10 indexed citations
12.
Xolalpa, Wendy, Patricia Pérez‐Galán, Manuel S. Rodríguez, & Gaël Roué. (2013). Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition. Current Pharmaceutical Design. 19(22). 4053–4093. 23 indexed citations
13.
Aillet, Fabienne, Fernando Lopitz‐Otsoa, Roland Hjerpe, et al.. (2012). Isolation of Ubiquitylated Proteins Using Tandem Ubiquitin-Binding Entities. Methods in molecular biology. 832. 173–183. 33 indexed citations
14.
Garcı́a, Juan Luis, Manuel S. Rodríguez, Antonio Pineda‐Lucena, et al.. (2012). GSK3-SCFFBXW7 targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase. Oncogene. 32(17). 2189–2199. 40 indexed citations
15.
Bossis, Guillaume, Cécile E. Malnou, Rosa Farrás, et al.. (2005). Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by Sumoylation. Molecular and Cellular Biology. 25(16). 6964–6979. 161 indexed citations
16.
Rodríguez, Manuel S., Catherine Dargemont, & Françoise Stutz. (2004). Nuclear export of RNA. Biology of the Cell. 96(8). 639–655. 132 indexed citations
17.
Vertegaal, Alfred C.O., Stephen C. Ogg, Ellis Jaffray, et al.. (2004). A Proteomic Study of SUMO-2 Target Proteins. Journal of Biological Chemistry. 279(32). 33791–33798. 184 indexed citations
18.
Rodríguez, Manuel S., Joana Desterro, Sonia Laı́n, et al.. (1999). SUMO-1 modification activates the transcriptional response of p53. The EMBO Journal. 18(22). 6455–6461. 541 indexed citations breakdown →
19.
Desterro, Joana, Manuel S. Rodríguez, Graham D. Kemp, & Ronald T. Hay. (1999). Identification of the Enzyme Required for Activation of the Small Ubiquitin-like Protein SUMO-1. Journal of Biological Chemistry. 274(15). 10618–10624. 299 indexed citations
20.
Rodríguez, Manuel S., Jill L. Thompson, Ronald T. Hay, & Catherine Dargemont. (1999). Nuclear Retention of IκBα Protects It from Signal-induced Degradation and Inhibits Nuclear Factor κB Transcriptional Activation. Journal of Biological Chemistry. 274(13). 9108–9115. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026